OMCL – Omnicell, Inc.
OMCL — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
8.17
Margin Of Safety %
54
Put/Call OI Ratio
0.28
EPS Next Q Diff
-0.33
EPS Last/This Y
2.23
EPS This/Next Y
-0.18
Price
36.82
Target Price
57.86
Analyst Recom
1.25
Performance Q
-15.05
Upside
-70.0%
Beta
0.98
Ticker: OMCL
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | OMCL | 46.68 | 1.47 | 0.96 | 2554 |
| 2026-07-14 | OMCL | 45.98 | 1.32 | 8.91 | 2687 |
| 2026-07-15 | OMCL | 46.84 | 1.34 | 0.50 | 2718 |
| 2026-07-16 | OMCL | 46.99 | 1.34 | 0.06 | 2722 |
| 2026-07-17 | OMCL | 45.84 | 1.33 | 0.60 | 2728 |
| 2026-07-20 | OMCL | 45.24 | 0.21 | 1.50 | 1362 |
| 2026-07-21 | OMCL | 41.8 | 0.22 | 0.89 | 1376 |
| 2026-07-22 | OMCL | 40.84 | 0.23 | 6.00 | 1402 |
| 2026-07-23 | OMCL | 39.83 | 0.31 | 2.00 | 1496 |
| 2026-07-24 | OMCL | 41.01 | 0.33 | 0.00 | 1514 |
| 2026-07-27 | OMCL | 41.49 | 0.33 | 0.00 | 1516 |
| 2026-07-28 | OMCL | 43.03 | 0.33 | 0.83 | 1517 |
| 2026-07-29 | OMCL | 41.33 | 0.33 | 0.45 | 1534 |
| 2026-07-30 | OMCL | 37.1 | 0.33 | 1.68 | 1539 |
| 2026-07-31 | OMCL | 35.4 | 0.34 | 0.03 | 1561 |
| 2026-08-03 | OMCL | 37.6 | 0.34 | 0.70 | 1569 |
| 2026-08-04 | OMCL | 37.12 | 0.31 | 2.00 | 1604 |
| 2026-08-05 | OMCL | 37.15 | 0.31 | 0.00 | 1609 |
| 2026-08-07 | OMCL | 36.78 | 0.28 | 0.10 | 1660 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | OMCL | 46.66 | 3.9 | - | 1.94 |
| 2026-07-14 | OMCL | 45.94 | 3.9 | - | 1.94 |
| 2026-07-15 | OMCL | 46.80 | 3.9 | - | 1.94 |
| 2026-07-16 | OMCL | 47.00 | 3.9 | - | 1.94 |
| 2026-07-17 | OMCL | 45.85 | 3.9 | - | 1.94 |
| 2026-07-20 | OMCL | 45.18 | 3.9 | - | 1.94 |
| 2026-07-21 | OMCL | 41.84 | 3.9 | - | 1.94 |
| 2026-07-22 | OMCL | 40.83 | 3.9 | - | 1.94 |
| 2026-07-23 | OMCL | 39.82 | 3.9 | - | 1.94 |
| 2026-07-24 | OMCL | 40.97 | 3.9 | - | 1.94 |
| 2026-07-27 | OMCL | 41.50 | 3.9 | - | 1.94 |
| 2026-07-28 | OMCL | 43.04 | 3.9 | - | 1.94 |
| 2026-07-29 | OMCL | 41.37 | 3.9 | - | 1.94 |
| 2026-07-30 | OMCL | 37.14 | 3.9 | - | 1.94 |
| 2026-07-31 | OMCL | 35.37 | 3.9 | - | 1.94 |
| 2026-08-03 | OMCL | 37.62 | 3.9 | - | 1.94 |
| 2026-08-04 | OMCL | 37.62 | 3.9 | - | 1.94 |
| 2026-08-05 | OMCL | 37.17 | -16.2 | - | 2.14 |
| 2026-08-06 | OMCL | 36.20 | -16.2 | - | 2.14 |
| 2026-08-07 | OMCL | 36.82 | -18.1 | - | 2.27 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | OMCL | -1.24 | 0.12 | 7.24 |
| 2026-07-14 | OMCL | -1.24 | 0.12 | 7.24 |
| 2026-07-15 | OMCL | -1.23 | 0.12 | 7.24 |
| 2026-07-16 | OMCL | -1.23 | 0.12 | 7.24 |
| 2026-07-17 | OMCL | -1.23 | 0.12 | 7.24 |
| 2026-07-20 | OMCL | -1.85 | -0.86 | 7.24 |
| 2026-07-21 | OMCL | -1.85 | -0.86 | 7.24 |
| 2026-07-22 | OMCL | -1.85 | -0.86 | 7.24 |
| 2026-07-23 | OMCL | -1.85 | -0.86 | 7.24 |
| 2026-07-24 | OMCL | -1.86 | -0.86 | 7.24 |
| 2026-07-27 | OMCL | -1.86 | -0.66 | 8.17 |
| 2026-07-28 | OMCL | -1.86 | -0.66 | 8.17 |
| 2026-07-29 | OMCL | -1.86 | -0.66 | 8.17 |
| 2026-07-30 | OMCL | -1.86 | -0.66 | 8.17 |
| 2026-07-31 | OMCL | -1.86 | -0.66 | 8.17 |
| 2026-08-03 | OMCL | -1.86 | -0.32 | 8.17 |
| 2026-08-04 | OMCL | -1.86 | -0.32 | 8.17 |
| 2026-08-05 | OMCL | -1.86 | -0.32 | 8.17 |
| 2026-08-06 | OMCL | -1.86 | -0.32 | 8.17 |
| 2026-08-07 | OMCL | -1.86 | -0.32 | 8.17 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.7
Avg. EPS Est. Current Quarter
0.42
Avg. EPS Est. Next Quarter
0.37
Insider Transactions
-1.86
Institutional Transactions
-0.32
Beta
0.98
Average Sales Estimate Current Quarter
304
Average Sales Estimate Next Quarter
310
Fair Value
56.82
Quality Score
49
Growth Score
69
Sentiment Score
33
Actual DrawDown %
80.3
Max Drawdown 5-Year %
-86.6
Target Price
57.86
P/E
43.53
Forward P/E
17.61
PEG
1.18
P/S
1.35
P/B
1.3
P/Free Cash Flow
11.98
EPS
0.85
Average EPS Est. Cur. Y
2.27
EPS Next Y. (Est.)
2.09
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
3.13
Relative Volume
1.07
Return on Equity vs Sector %
-24.3
Return on Equity vs Industry %
-7.7
EPS 1 7Days Diff
0.3
EPS 1 30Days Diff
0.33
EBIT Estimation
◆
OMCL
Healthcare
$36.81
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
38.7
Range 1M
17.9%
Sup Dist
3.1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
40.1%
EPS NY
-7.9%
52W%
31.5%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+14.7% upside
Upside
+14.7%
Quality
49
MoS
54%
OMCL — P/E HistoricalHealth Information Services
Omnicell, Inc.Sector: Healthcare
Industry: Health Information Services
Employees: 3485
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
OMCL
Latest News
—
Caricamento notizie per OMCL…
stock quote shares OMCL – Omnicell, Inc. Stock Price stock today
news today OMCL – Omnicell, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OMCL – Omnicell, Inc. yahoo finance google finance
stock history OMCL – Omnicell, Inc. invest stock market
stock prices OMCL premarket after hours
ticker OMCL fair value insiders trading